Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

83%

5 of 6 completed trials have results

Key Signals

5 with results

Enrollment Performance

Analytics

Phase 1

6(85.7%)

Phase 4

1(14.3%)

7Total

Phase 1(6)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT00902512Phase 4Completed

Study Of Bioavailability Of Two Sildenafil 100mg Oral Tablet Formulations

Role: collaborator

NCT01046162Phase 1Withdrawn

A Study Of Two Oral Preparations Of 2 Mg Alprazolam In Healthy Volunteers Under Fasting Conditions

Role: collaborator

NCT02490670Phase 1Completed

A Study of Cephalexin Liquid in Healthy Participants

Role: collaborator

NCT02123446Phase 1Completed

A Study of Cephalexin Capsules in Healthy Participants

Role: collaborator

NCT02123472Phase 1Completed

A Study of Cephalexin Liquid for Pediatrics in Healthy Adults Participants

Role: collaborator

NCT02123459Phase 1Completed

A Study of Cephalexin Suspension in Healthy Participants

Role: collaborator

NCT02100826Phase 1Completed

A Study of Cephalexin in Healthy Participants

Role: collaborator

All 7 trials loaded